At a glance
- Originator Fujisawa
- Class Small molecules
- Mechanism of Action Cholinergic receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Pollakisuria
Most Recent Events
- 23 Jun 1998 Commercial data has been reviewed by Fujisawa
- 23 Jun 1998 Discontinued-II for Pollakisuria in Japan (Unknown route)
- 17 May 1996 New profile